136 related articles for article (PubMed ID: 2182675)
1. Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Jones RN
J Clin Microbiol; 1990 Mar; 28(3):605-7. PubMed ID: 2182675
[TBL] [Abstract][Full Text] [Related]
2. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Thornsberry C; Gavan TL
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
[TBL] [Abstract][Full Text] [Related]
3. Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
Jones RN; Barry AL
J Clin Microbiol; 1987 Nov; 25(11):2211-3. PubMed ID: 3121667
[TBL] [Abstract][Full Text] [Related]
4. Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.
Barry AL; Thornsberry C; Jones RN; Gavan TL
J Clin Microbiol; 1984 Jun; 19(6):777-82. PubMed ID: 6432833
[TBL] [Abstract][Full Text] [Related]
5. Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN 58 940 method.
Kleinkauf N; Rodloff AC
Clin Microbiol Infect; 2001 Jun; 7(6):326-30. PubMed ID: 11442566
[TBL] [Abstract][Full Text] [Related]
6. Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests.
Barry AL; Gavan TL; Thornsberry C; Jones RN
J Clin Microbiol; 1985 Oct; 22(4):688-90. PubMed ID: 4077974
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.
Jones RN; Barry AL
Antimicrob Agents Chemother; 1988 Oct; 32(10):1576-82. PubMed ID: 3190185
[TBL] [Abstract][Full Text] [Related]
8. Disk diffusion interpretive criteria for extended-spectrum cephalosporins with Haemophilus influenzae.
Jorgensen JH; Maher LA; Redding JS
J Clin Microbiol; 1988 Sep; 26(9):1887-9. PubMed ID: 3263388
[TBL] [Abstract][Full Text] [Related]
9. Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium.
Pfaller MA; Jones RN; Washington JA; Koontz FP; Gerlach EH; Erwin ME
Diagn Microbiol Infect Dis; 1992 Feb; 15(2):145-50. PubMed ID: 1315231
[TBL] [Abstract][Full Text] [Related]
10. Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
Doern GV; Jones RN; Gerlach EH; Hindler J; St Amand R
Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):481-9. PubMed ID: 7957268
[TBL] [Abstract][Full Text] [Related]
11. Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.
Barry AL; Thornsberry C; Jones RN; Gavan TL
Rev Infect Dis; 1985; 7 Suppl 4():S594-604. PubMed ID: 3909316
[TBL] [Abstract][Full Text] [Related]
12. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
Fuchs PC; Jones RN; Barry AL; Gavan TL
J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
[TBL] [Abstract][Full Text] [Related]
13. Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines.
Jones RN; Barry AL; Thornsberry C
J Clin Microbiol; 1983 Jul; 18(1):211-4. PubMed ID: 6350348
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.
Jones RN; Barry AL
J Clin Microbiol; 1987 Nov; 25(11):2243-6. PubMed ID: 3693552
[TBL] [Abstract][Full Text] [Related]
15. Ceftibuten (7432-S, SCH 39720): comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines.
Jones RN; Barry AL
Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):802-7. PubMed ID: 3145869
[TBL] [Abstract][Full Text] [Related]
16. Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzae.
Barrett MS; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):462-5. PubMed ID: 1330563
[TBL] [Abstract][Full Text] [Related]
17. Provisional quality control parameters and interpretive criteria for testing susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to quinupristin/dalfopristin (RP59500). Antimicrobial Testing Quality Control Group.
Fuchs P; Barry A; Brown S
Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):197-201. PubMed ID: 9665303
[TBL] [Abstract][Full Text] [Related]
18. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
Zerva L; Biedenbach DJ; Jones RN
J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
[TBL] [Abstract][Full Text] [Related]
19. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992; 15(8):693-701. PubMed ID: 1478050
[TBL] [Abstract][Full Text] [Related]
20. Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.
Bale MJ; Jones RN; Erwin ME; Koontz FP; Gerlach EH; Murray PR; Washington JA
J Clin Microbiol; 1992 Mar; 30(3):744-5. PubMed ID: 1313052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]